BIO-RAD LABORATORIES -CL B (BIO.B) Stock Analyst Ratings
USA - NYSE:BIO.B - US0905721082 - Common Stock
310.7 USD
-3.7 (-1.18%)
ChartMill assigns a Buy % Consensus number of 76% to BIO.B. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 369.39. This target is 18.89% above the current price.
BIO.B was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BIO.B.
In the previous month the buy percentage consensus was at a similar level.
BIO.B was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-30 | Wells Fargo | Maintains | Overweight |
| 2021-02-12 | Citigroup | Maintains | Buy |
BIO-RAD LABORATORIES -CL B / BIO.B FAQ
What is the average price target for BIO-RAD LABORATORIES -CL B (BIO.B) stock?
10 analysts have analysed BIO.B and the average price target is 369.39 USD. This implies a price increase of 18.89% is expected in the next year compared to the current price of 310.7.
What is the consensus rating for BIO.B stock?
The consensus rating for BIO-RAD LABORATORIES -CL B (BIO.B) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.